Fady Ibraham Malik - 11 Jun 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Malik
Issuer symbol
CYTK
Transactions as of
11 Jun 2024
Net transactions value
-$369,947
Form type
4
Filing time
11 Jun 2024, 16:22:59 UTC
Previous filing
07 May 2024
Next filing
20 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $43,159 +5,422 +3.9% $7.96 142,792 11 Jun 2024 Direct
transaction CYTK Common Stock Sale $287,637 -5,422 -3.8% $53.05 137,370 11 Jun 2024 Direct
transaction CYTK Common Stock Sale $125,469 -2,366 -1.7% $53.03 135,004 11 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -5,422 -7.3% $0.000000 68,900 11 Jun 2024 Common Stock 5,422 $7.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).